首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Effects of Raupya Suvarna Sutashekhara, a herbo-mineral-metallic formulation as adjunct Oral Ayurvedic Medicine on long-term survival in patients of malignant brain tumor Raupya Suvarna Sutashekhara(一种辅助口服阿育吠陀药的矿物金属制剂)对恶性脑肿瘤患者长期生存的影响
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.101070
Sadanand Sardeshmukh, Vineeta Deshmukh, Arvind Kulkarni, Swapna Kulkarni, Vasanti Godse, Shrinivas Datar, Sushama Bhuvad, Shweta Gujar, Sameer Gore, Bhagyashree Sardeshmukh, Vinita Awalkanthe, Anita Shingte, Sneha Dalvi, Vijay Radye, Sandeep Chavan

Background

The incidence of brain tumors poses a significant threat, particularly with high-grade tumors that exhibit rapid growth and can significantly impair the patient's quality of life, despite treatment modalities. Ayurveda, a natural system of medicines helps to enhance health benefits when used as a complementary therapy in combination with conventional treatment through various herbal, herbo-mineral or herbo-mineral-metallic formulations. One of such formulations, Raupya Suvarna Sutshekhara (RSS), has Raupya bhasma and Suvarna bhasma (incinerated Silver and Gold respectively) ingredients and they are described as Rasayana (immunomodulatory) and possess Medhya (enhances the brain functions and intelligence) activity.

Objective

The study documents effects of Raupya Suvarna Sutshekhara in alleviating symptoms of malignant brain tumors.

Materials and methods

This retrospective cohort study was done for malignant brain tumor patients (n = 110) registered at our centre who were treated with Raupya Suvarna Sutshekhara 125 mg–250 mg (a herbo-mineral metallic formulation) as a treatment of choice of neural tonic along with supporting Ayurvedic medicines. Treatment response evaluation period ranged from 3 months to 5 years (median period 29 weeks). Clinical symptoms, weight, Karnofsky Performance Score (KPS), Quality of Life (QoL) score, and survival data with respect to treatment with RSS were analyzed.

Results

RSS showed a very significant (p < 0.001) effect on symptoms related to memory loss, headache, imbalance, loss of appetite, and generalized weakness while significant (p < 0.05) decrease in urinary incontinence, seizures, difficulty in thinking/articulating, and weakness in one part/side of the body. However, a not-quite significant change was seen in symptom confusion/disorientation. No significant improvement was seen in vision changes, facial numbness or tingling, swallowing difficulties, and tingling in extremities. Body weight and KPS also showed improvement. Patients with treatment between 2 and 5 years showed median survival up to 62 months.

Conclusions

It was observed that adjunct Ayurvedic treatment with RSS helped to reduce the severity of symptoms due to the tumor itself or side-effects of conventional treatments, maintain the quality of life of malignant brain tumor patients and has shown to increase survival with respect to the duration of the treatment.
背景脑肿瘤的发病率构成了重大威胁,尤其是生长迅速的高级别肿瘤,尽管采用了各种治疗方法,但仍会严重影响患者的生活质量。阿育吠陀是一种天然药物系统,它通过各种草药、矿物或矿物-矿物-金属配方作为辅助疗法与传统疗法相结合,有助于提高健康效益。其中一种配方是 Raupya Suvarna Sutshekhara(RSS),含有 Raupya bhasma 和 Suvarna bhasma(分别为焚烧银和金)成分,被称为 Rasayana(免疫调节),具有 Medhya(增强大脑功能和智力)活性。材料和方法这项回顾性队列研究的对象是在本中心登记的恶性脑肿瘤患者(n = 110),他们接受了 Raupya Suvarna Sutshekhara 125 毫克-250 毫克(一种草本矿物质金属制剂)的治疗,作为神经滋补剂的首选治疗方法,同时服用辅助的阿育吠陀药物。治疗反应评估期为 3 个月至 5 年(中位数为 29 周)。结果RSS对记忆力减退、头痛、失衡、食欲不振和全身乏力等相关症状有非常显著的疗效(p <0.001),而对尿失禁、癫痫发作、思维/发音困难和身体某一部分/一侧乏力有显著的疗效(p <0.05)。然而,症状混乱/精神错乱的变化并不明显。视力变化、面部麻木或刺痛、吞咽困难和四肢刺痛等症状没有明显改善。体重和 KPS 也有改善。结论 据观察,RSS 的辅助阿育吠陀疗法有助于减轻因肿瘤本身或常规治疗的副作用而引起的症状的严重程度,保持恶性脑肿瘤患者的生活质量,并在治疗期间提高了生存率。
{"title":"Effects of Raupya Suvarna Sutashekhara, a herbo-mineral-metallic formulation as adjunct Oral Ayurvedic Medicine on long-term survival in patients of malignant brain tumor","authors":"Sadanand Sardeshmukh,&nbsp;Vineeta Deshmukh,&nbsp;Arvind Kulkarni,&nbsp;Swapna Kulkarni,&nbsp;Vasanti Godse,&nbsp;Shrinivas Datar,&nbsp;Sushama Bhuvad,&nbsp;Shweta Gujar,&nbsp;Sameer Gore,&nbsp;Bhagyashree Sardeshmukh,&nbsp;Vinita Awalkanthe,&nbsp;Anita Shingte,&nbsp;Sneha Dalvi,&nbsp;Vijay Radye,&nbsp;Sandeep Chavan","doi":"10.1016/j.jaim.2024.101070","DOIUrl":"10.1016/j.jaim.2024.101070","url":null,"abstract":"<div><h3>Background</h3><div>The incidence of brain tumors poses a significant threat, particularly with high-grade tumors that exhibit rapid growth and can significantly impair the patient's quality of life, despite treatment modalities. Ayurveda, a natural system of medicines helps to enhance health benefits when used as a complementary therapy in combination with conventional treatment through various herbal, herbo-mineral or herbo-mineral-metallic formulations. One of such formulations, <em>Raupya Suvarna Sutshekhara (RSS),</em> has <em>Raupya bhasma</em> and <em>Suvarna bhasma</em> (incinerated Silver and Gold respectively) ingredients and they are described as <em>Rasayana</em> (immunomodulatory) and possess <em>Medhya</em> (enhances the brain functions and intelligence) activity.</div></div><div><h3>Objective</h3><div>The study documents effects of <em>Raupya Suvarna Sutshekhara</em> in alleviating symptoms of malignant brain tumors.</div></div><div><h3>Materials and methods</h3><div>This retrospective cohort study was done for malignant brain tumor patients (n = 110) registered at our centre who were treated with <em>Raupya Suvarna Sutshekhara</em> 125 mg–250 mg (a herbo-mineral metallic formulation) as a treatment of choice of neural tonic along with supporting Ayurvedic medicines. Treatment response evaluation period ranged from 3 months to 5 years (median period 29 weeks). Clinical symptoms, weight, Karnofsky Performance Score (KPS), Quality of Life (QoL) score, and survival data with respect to treatment with RSS were analyzed.</div></div><div><h3>Results</h3><div>RSS showed a very significant (<em>p</em> &lt; 0.001) effect on symptoms related to memory loss, headache, imbalance, loss of appetite, and generalized weakness while significant (<em>p</em> &lt; 0.05) decrease in urinary incontinence, seizures, difficulty in thinking/articulating, and weakness in one part/side of the body. However, a not-quite significant change was seen in symptom confusion/disorientation. No significant improvement was seen in vision changes, facial numbness or tingling, swallowing difficulties, and tingling in extremities. Body weight and KPS also showed improvement. Patients with treatment between 2 and 5 years showed median survival up to 62 months.</div></div><div><h3>Conclusions</h3><div>It was observed that adjunct Ayurvedic treatment with RSS helped to reduce the severity of symptoms due to the tumor itself or side-effects of conventional treatments, maintain the quality of life of malignant brain tumor patients and has shown to increase survival with respect to the duration of the treatment.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 101070"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142446630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda management of migraine - a case report 偏头痛的阿育吠陀疗法--病例报告。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.100983
Giramalla Patil , Shivanand Patil , Prateek Hosur
Migraine is one of the most prevalent causes of functional disability worldwide. Migraine patients experience headaches of varying degrees, which are related with a higher level of disability and are triggered by psychological and physiological stressors. Migraine is estimated to affect 16.6% of the world's population, with women being three times more likely to experience it than men. Despite considerable advancements in modern and traditional medicine, a complete cure remains uncertain. In Ayurvedic treatises, migraine headache is referred to as Ardhavabedhaka under the classification of Shiroroga (diseases related to the head region).
35-year-old Indian male police inspector, suffering from recurrent right hemi-cranial headaches once in three days for the last three months, presented symptoms of Tridhoshaja Ardhvabhedaka (Migraine) associated with Amlapitta (hyperacidity).
After a thorough assessment of the patient, the treatment was meticulously planned based on the patient's Dosha pradhanyatha and Vyadhi avastha (stage of disease). For the proper Samprapti vighatana, Nidana parivarjana (abstinance from the eitiological factors), Deepana, Paachana, Siravyadha, Nasya and Dosha Shamana Chikitsa principles were adopted. Further, the severity of the migraine was assessed by MIDAS and NPR score, which subsequently decreased from 19 to 4, and the NPR scale decreased from 8 to 2 till completion of the therapeutic intervention.
This case report unequivocally highlights the pivotal role of the Ayurveda treatment regimen in effectively managing migraine. Overall, effective treatment of migraine cases requires the correct assessment of Dosha status and Vyadhi avastha and the correct selection of the appropriate medicine and procedures like Siravyadha and Nasya at that appropriate stage of the disease.
偏头痛是导致全球功能性残疾的最普遍原因之一。偏头痛患者会出现不同程度的头痛,与较高程度的残疾有关,是由心理和生理压力引发的。据估计,偏头痛影响着全球 16.6% 的人口,女性患偏头痛的几率是男性的三倍。尽管现代医学和传统医学都取得了长足的进步,但仍无法彻底治愈偏头痛。在阿育吠陀医学论文中,偏头痛被归入 "Shiroroga"(与头部有关的疾病)分类下的 "Ardhavabedhaka"。35 岁的印度男性警务督察在过去三个月中反复出现右侧半颅骨头痛,三天一次,症状为 Tridhoshaja Ardhvabhedaka(偏头痛),伴有 Amlapitta(胃酸过多)。在对患者进行全面评估后,根据患者的 Dosha pradhanyatha 和 Vyadhi avastha(疾病阶段)精心制定了治疗方案。为了采用适当的 Samprapti vighatana、Nidana parivarjana(戒除致病因素)、Deepana、Paachana、Siravyadha、Nasya 和 Dosha ShamanaChikitsa 原则。此外,通过 MIDAS 和 NPR 评分评估偏头痛的严重程度,偏头痛评分随后从 19 分降至 4 分,NPR 评分从 8 分降至 2 分,直至治疗干预结束。本病例报告明确强调了阿育吠陀疗法在有效控制偏头痛方面的关键作用。总之,要有效治疗偏头痛,就必须正确评估 Dosha 状态和 Vyadhi avastha,并在疾病的适当阶段正确选择适当的药物和程序,如 Siravyadha 和 Nasya。
{"title":"Ayurveda management of migraine - a case report","authors":"Giramalla Patil ,&nbsp;Shivanand Patil ,&nbsp;Prateek Hosur","doi":"10.1016/j.jaim.2024.100983","DOIUrl":"10.1016/j.jaim.2024.100983","url":null,"abstract":"<div><div>Migraine is one of the most prevalent causes of functional disability worldwide. Migraine patients experience headaches of varying degrees, which are related with a higher level of disability and are triggered by psychological and physiological stressors. Migraine is estimated to affect 16.6% of the world's population, with women being three times more likely to experience it than men. Despite considerable advancements in modern and traditional medicine, a complete cure remains uncertain. In <em>Ayurvedic</em> treatises, migraine headache is referred to as <em>Ardhavabedhaka</em> under the classification of <em>Shiroroga</em> (diseases related to the head region).</div><div>35-year-old Indian male police inspector, suffering from recurrent right hemi-cranial headaches once in three days for the last three months, presented symptoms of <em>Tridhoshaja Ardhvabhedaka</em> (Migraine) associated with <em>Amlapitta</em> (hyperacidity).</div><div>After a thorough assessment of the patient, the treatment was meticulously planned based on the patient's <em>Dosha pradhanyatha</em> and <em>Vyadhi avastha</em> <em>(stage of disease)</em>. For the proper <em>Samprapti vighatana, Nidana parivarjana</em> (abstinance from the eitiological factors), <em>Deepana, Paachana, Siravyadha</em>, <em>Nasya</em> and <em>Dosha Shaman</em><em>a</em> <em>Chikitsa</em> principles were adopted. Further, the severity of the migraine was assessed by MIDAS and NPR score, which subsequently decreased from 19 to 4, and the NPR scale decreased from 8 to 2 till completion of the therapeutic intervention.</div><div>This case report unequivocally highlights the pivotal role of the Ayurveda treatment regimen in effectively managing migraine. Overall, effective treatment of migraine cases requires the correct assessment of <em>Dosha</em> status and <em>Vyadhi avastha</em> and the correct selection of the appropriate medicine and procedures like <em>Siravyadha and Nasya</em> at that appropriate stage of the disease.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 100983"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of systemic sclerosis - A case report 系统性硬化症的阿育吠陀疗法--病例报告
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.100956
Jagruti R. Parmar , Naiya Upadhyay , Manish V. Patel , Shivenarain N. Gupta

Scleroderma, an autoimmune connective tissue disorder, leads to skin and tissue thickening. In this autoimmune disease condition, the defense mechanism works against the body itself and mistakenly attacks normal cells. Ayurveda links it to vatarakta, initially affecting tvak, rakta, and mamsa. Vata is primarily involved, but as the disease progresses, all doshas and dhatu get involved.

A 45-year-old woman presented with skin hardening, skin depigmentation all over her body, limb stiffness, weakness, arthralgia, anorexia, constipation and burning in the chest region for the last three years.

She was diagnosed with diffuse systemic sclerosis (SSc) but as per Ayurveda we can correlate with aamvata and vatarakta based on her lakshanas(symptoms).

Ayurvedic treatment commenced with vardhamana pippali(Piper longum)rasayan, svedana karma, and virechan karma, followed by basti(enema) chikitsa (pathyadi kvath niruh basti) and oral ayurvedic medication viz., Manjisthadi kvatha, kaishora guggulu, Jatamansi(Nardostachys Jatamansi) churna, mishreya(Foeniculum vulgare) arka, dashang churna with water for local application and daily shamanarth panchtikta ghrit.

After 8 weeks, depigmentation was reduced, new hair growth emerged, mild skin softening occured, chest burning, anorexia, sleeplessness was decreased and enhanced mental well-being.

The treatment aimed to balance vitiated doshas and dhatu while alleviating symptoms, and enhancing overall well-being, demonstrating the efficacy of the holistic approach in managing scleroderma through Ayurveda.

Auto-immune disorder, scleroderma, chronic complications, skin tightness, salt pepper depigmentation, sclerodactyly.

硬皮病是一种自身免疫性结缔组织疾病,会导致皮肤和组织增厚。在这种自身免疫性疾病中,防御机制对身体本身起作用,错误地攻击正常细胞。阿育吠陀将其与 vatarakta 联系在一起,最初会影响 tvak、rakta 和 mamsa。一名 45 岁的女性在过去三年中出现了皮肤变硬、全身皮肤色素沉着、四肢僵硬、无力、关节痛、厌食、便秘和胸部烧灼感。她被诊断为弥漫性系统性硬化症(SSc),但根据阿育吠陀,我们可以根据她的 lakshanas(症状)将其与 aamvata 和 vatarakta 联系起来。阿育吠陀治疗开始于 vardhamana pippali(Piper longum)rasayan、svedana karma 和 virechan karma,随后是 basti(灌肠)chikitsa(patyadi kvath niruh basti)和口服阿育吠陀药物,即:Manjisthadi kvatha、Manjisthadi kvatha、Manjisthadi kvatha、Manjisthadi kvatha、Manjisthadi kvatha、Manjisthadi kvatha、Manjisthadi kvatha、8 周后,患者的色素沉着有所减轻,新的毛发开始生长,皮肤轻度变软,胸部烧灼感、厌食和失眠症状有所减轻,精神状态也有所改善。治疗的目的是平衡受损的道舒和道图,同时减轻症状,提高整体健康水平,这证明了通过阿育吠陀疗法治疗硬皮病的整体方法的有效性。
{"title":"Ayurvedic management of systemic sclerosis - A case report","authors":"Jagruti R. Parmar ,&nbsp;Naiya Upadhyay ,&nbsp;Manish V. Patel ,&nbsp;Shivenarain N. Gupta","doi":"10.1016/j.jaim.2024.100956","DOIUrl":"10.1016/j.jaim.2024.100956","url":null,"abstract":"<div><p>Scleroderma, an autoimmune connective tissue disorder, leads to skin and tissue thickening. In this autoimmune disease condition, the defense mechanism works against the body itself and mistakenly attacks normal cells. Ayurveda links it to <em>vatarakta</em>, initially affecting <em>tvak</em>, <em>rakta</em>, and <em>mamsa</em>. <em>Vata</em> is primarily involved, but as the disease progresses, all <em>doshas</em> and <em>dhatu</em> get involved.</p><p>A 45-year-old woman presented with skin hardening, skin depigmentation all over her body, limb stiffness, weakness, arthralgia, anorexia, constipation and burning in the chest region for the last three years.</p><p>She was diagnosed with diffuse systemic sclerosis (SSc) but as per Ayurveda we can correlate with <em>aamvata</em> and <em>vatarakta</em> based on her <em>lakshanas</em>(symptoms).</p><p>Ayurvedic treatment commenced with <em>vardhamana pippali</em>(<em>Piper longum</em>)<em>rasayan</em>, <em>svedana karma</em>, and <em>virechan karma</em>, followed by <em>basti</em>(enema) <em>chikitsa (pathyadi kvath niruh basti)</em> and oral ayurvedic medication viz., <em>Manjisthadi kvatha</em>, <em>kaishora guggulu</em>, <em>Jatamansi(Nardostachys Jatamansi) churna, mishreya(Foeniculum vulgare) arka, dashang churna</em> with water for local application and daily <em>shamanarth panchtikta ghrit.</em></p><p>After 8 weeks, depigmentation was reduced, new hair growth emerged, mild skin softening occured, chest burning, anorexia, sleeplessness was decreased and enhanced mental well-being.</p><p>The treatment aimed to balance vitiated doshas and dhatu while alleviating symptoms, and enhancing overall well-being, demonstrating the efficacy of the holistic approach in managing scleroderma through Ayurveda.</p><p>Auto-immune disorder, scleroderma, chronic complications, skin tightness, salt pepper depigmentation, sclerodactyly.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 100956"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000718/pdfft?md5=da9d36f463e172d0440b1f4e0ad8b25e&pid=1-s2.0-S0975947624000718-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multi-center, randomized, open label, two-arm study to evaluate safety & efficacy of nutraceutical tablet as adjuvant when compared with standard of care in patients with benign prostatic hyperplasia 这是一项多中心、随机、开放标签、双臂研究,旨在评估良性前列腺增生患者将营养保健品片剂作为辅助治疗与标准治疗相比的安全性和有效性。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.100971
Suresh B. Patankar , Anupama Patankar , Sagar Patankar , Rajesh Raje , Chandu Devanpally , Pranjal Ausekar , GauravPatil , Shraddha Chitale

Background

Benign Prostrate Hyperplasia (BPH) is a progressive disease of ageing men that may be associated with enlargement of the prostate and lower urinary tract symptoms (LUTS). Herbal/Nutraceutical formulations in addition to standard of care (SOC) could alleviate the symptoms, and thus improve the quality of life of patients.

Objectives

To evaluate safety & efficacy of nutraceutical tablet as an adjuvant with SOC.

Materials and Methods

This was a prospective, randomized two-arm study aimed to assess the safety and efficacy of Herbal/Nutraceutical Formulation (IP) + SOC versus only SOC, in BPH patients. The primary efficacy endpoint was the change in international prostate symptom score (IPSS) within and between two arms. The safety was evaluated in terms of adverse events and change in prostate specific antigen (PSA) levels.

Results

140 eligible patients (70 / arm) were evaluated for efficacy and safety endpoints. The baseline characteristics of patients in two arms differed nonsignificantly. The change in IPSS-storage, voiding and QoL scores, from day 1 to 90 were statistically significant in both the arms (p < 0.0001). However, by day 90, the change in these scores in SOC+IP arm were significantly higher than that of SOC arm. Further, the change in International Index of Erectile Function (IIEF) scores was significant in SOC+IP arm (p < 0.05), while non-significant in SOC arm. The adverse events non-significantly differed between two arms.

Conclusion

The herbal/nutraceutical formulation combined with SOC are safe and effective for the treatment of BPH. The combination therapy was effective in reducing urine-related symptoms and improving the QoL of BPH patients.
背景:良性前列腺增生症(BPH)是一种渐进性老年男性疾病,可能与前列腺增生和下尿路症状(LUTS)有关。除标准治疗(SOC)外,草药/保健品配方可减轻症状,从而改善患者的生活质量:材料与方法:这是一项前瞻性随机对照研究:这是一项前瞻性随机双臂研究,旨在评估前列腺增生症患者服用草药/保健品制剂(IP)+SOC 与仅服用 SOC 的安全性和有效性。主要疗效终点是两组患者体内和两组之间国际前列腺症状评分(IPSS)的变化。安全性则根据不良事件和前列腺特异性抗原(PSA)水平的变化进行评估:对 140 名符合条件的患者(70 人/组)进行了疗效和安全性终点评估。两组患者的基线特征差异不大。从第 1 天到第 90 天,两组患者的 IPSS-储尿、排尿和 QoL 评分的变化均有统计学意义(P < 0.0001)。然而,到第 90 天,SOC+IP 治疗组的这些评分变化明显高于 SOC 治疗组。此外,国际勃起功能指数(IIEF)评分的变化在 SOC+IP 组显著(p < 0.05),而在 SOC 组不显著。两组的不良反应差异不显著:结论:草药/保健品配方与SOC联合治疗良性前列腺增生症安全有效。联合疗法能有效减轻良性前列腺增生患者的尿相关症状,改善其生活质量。
{"title":"A multi-center, randomized, open label, two-arm study to evaluate safety & efficacy of nutraceutical tablet as adjuvant when compared with standard of care in patients with benign prostatic hyperplasia","authors":"Suresh B. Patankar ,&nbsp;Anupama Patankar ,&nbsp;Sagar Patankar ,&nbsp;Rajesh Raje ,&nbsp;Chandu Devanpally ,&nbsp;Pranjal Ausekar ,&nbsp;GauravPatil ,&nbsp;Shraddha Chitale","doi":"10.1016/j.jaim.2024.100971","DOIUrl":"10.1016/j.jaim.2024.100971","url":null,"abstract":"<div><h3>Background</h3><div>Benign Prostrate Hyperplasia (BPH) is a progressive disease of ageing men that may be associated with enlargement of the prostate and lower urinary tract symptoms (LUTS). Herbal/Nutraceutical formulations in addition to standard of care (SOC) could alleviate the symptoms, and thus improve the quality of life of patients.</div></div><div><h3>Objectives</h3><div>To evaluate safety &amp; efficacy of nutraceutical tablet as an adjuvant with SOC.</div></div><div><h3>Materials and Methods</h3><div>This was a prospective, randomized two-arm study aimed to assess the safety and efficacy of Herbal/Nutraceutical Formulation (IP) + SOC versus only SOC, in BPH patients. The primary efficacy endpoint was the change in international prostate symptom score (IPSS) within and between two arms. The safety was evaluated in terms of adverse events and change in prostate specific antigen (PSA) levels.</div></div><div><h3>Results</h3><div>140 eligible patients (70 / arm) were evaluated for efficacy and safety endpoints. The baseline characteristics of patients in two arms differed nonsignificantly. The change in IPSS-storage, voiding and QoL scores, from day 1 to 90 were statistically significant in both the arms (p &lt; 0.0001). However, by day 90, the change in these scores in SOC+IP arm were significantly higher than that of SOC arm. Further, the change in International Index of Erectile Function (IIEF) scores was significant in SOC+IP arm (p &lt; 0.05), while non-significant in SOC arm. The adverse events non-significantly differed between two arms.</div></div><div><h3>Conclusion</h3><div>The herbal/nutraceutical formulation combined with SOC are safe and effective for the treatment of BPH. The combination therapy was effective in reducing urine-related symptoms and improving the QoL of BPH patients.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 100971"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142500983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Ayurvedic philosophy with modern technologies for drug research and development: A critical need of mechanistic insights for wider acceptability 将阿育吠陀哲学与现代药物研发技术相结合:亟需深入了解机理,以获得更广泛的可接受性。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.100954
Chavan Sandeep , Vidya Gupta , Vineeta Deshmukh , Sadanand Sardeshmukh
Ayurveda is a holistic science emphasizing healing and maintaining harmony and balance in the body. Medicines from natural resources and in pre-defined dosage forms are integral parts of successful Ayurvedic treatment in various diseases including complex ailments, such as cancer. Ayurvedic medicines are cocktails of several active phyto-compounds and/or natural resources and no isolated/purified molecules are used in the treatment. However, various unique methods employed using natural media, such as water, lipids, buttermilk, and lemon juice, just to name a few, lead to the elimination of unwanted constituents/impurities and enhance the bioavailability and efficacy of the drug. Such plausible alterations, selection, and/or retention of signature phytocompounds in the raw materials, during the process, and in the final drug need to be studied for precise product identification and analysis. Critical standardization of the manufacturing procedures is, therefore, mandatory for quality fidelity, assurance, and optimum efficacy. Moreover, the simultaneous multi-level and/or multi-targeted actions of Ayurvedic medicines against various dysfunctions due to their complex nature makes it extremely challenging to understand the mechanistic aspects during pre-clinical and clinical studies.
The present article focuses on probable challenges and ideal roadmaps for standardization and characterization of such herbal as well as metallic-mineral Ayurvedic medicines being used for various simple and complex diseases like cancer and their treatments. It is emphasized that Ayurvedic manufacturing procedures should be followed meticulously and the finished product be characterized thoroughly using advanced pharmaceutical and analytical techniques. It is also accentuated that detailed monographs or dossiers including shelf-life studies need to be officially published for knowledge dissemination and worldwide acceptance. Finally, safety and efficacy studies as per modern pharmacology ought to be conducted in suitable animal models for the judicious use of these medicines. Mainstream or adjuvant treatment of dreadful diseases such as cancer with Ayurvedic medicines will only be fruitful through rational experimentation and ethical reporting.
阿育吠陀是一门整体科学,强调治疗和保持身体的和谐与平衡。来自天然资源的药物和预先确定的剂型是阿育吠陀疗法成功治疗各种疾病(包括癌症等复杂疾病)不可或缺的组成部分。阿育吠陀药物是几种活性植物化合物和/或自然资源的混合体,治疗中不使用分离/提纯的分子。不过,阿育吠陀药物采用各种独特的方法,利用天然介质(如水、脂质、酪乳和柠檬汁等)去除不需要的成分/杂质,提高药物的生物利用度和疗效。需要对原材料、加工过程和最终药物中的此类似是而非的改变、选择和/或特征植物化合物的保留进行研究,以便对产品进行精确的鉴定和分析。因此,为了保证质量的真实性、可靠性和最佳疗效,必须对生产程序进行严格的标准化。此外,由于阿育吠陀药物性质复杂,同时具有多层次和/或多靶点作用,可用于治疗各种功能障碍,因此在临床前和临床研究中了解其机理方面的问题极具挑战性。本文重点介绍了用于癌症等各种简单和复杂疾病及其治疗的阿育吠陀草药和金属矿物药在标准化和表征方面可能面临的挑战和理想的路线图。文章强调,应严格遵守阿育吠陀药的生产程序,并利用先进的制药和分析技术对成品进行彻底表征。此外,还强调需要正式出版详细的专著或档案,包括保质期研究,以传播知识并为全世界所接受。最后,还应在合适的动物模型中进行现代药理学的安全性和有效性研究,以便合理使用这些药物。只有通过合理的实验和合乎伦理的报告,阿育吠陀药物对癌症等可怕疾病的主流或辅助治疗才能取得成效。
{"title":"Integrating Ayurvedic philosophy with modern technologies for drug research and development: A critical need of mechanistic insights for wider acceptability","authors":"Chavan Sandeep ,&nbsp;Vidya Gupta ,&nbsp;Vineeta Deshmukh ,&nbsp;Sadanand Sardeshmukh","doi":"10.1016/j.jaim.2024.100954","DOIUrl":"10.1016/j.jaim.2024.100954","url":null,"abstract":"<div><div>Ayurveda is a holistic science emphasizing healing and maintaining harmony and balance in the body. Medicines from natural resources and in pre-defined dosage forms are integral parts of successful Ayurvedic treatment in various diseases including complex ailments, such as cancer. Ayurvedic medicines are cocktails of several active phyto-compounds and/or natural resources and no isolated/purified molecules are used in the treatment. However, various unique methods employed using natural media, such as water, lipids, buttermilk, and lemon juice, just to name a few, lead to the elimination of unwanted constituents/impurities and enhance the bioavailability and efficacy of the drug. Such plausible alterations, selection, and/or retention of signature phytocompounds in the raw materials, during the process, and in the final drug need to be studied for precise product identification and analysis. Critical standardization of the manufacturing procedures is, therefore, mandatory for quality fidelity, assurance, and optimum efficacy. Moreover, the simultaneous multi-level and/or multi-targeted actions of Ayurvedic medicines against various dysfunctions due to their complex nature makes it extremely challenging to understand the mechanistic aspects during pre-clinical and clinical studies.</div><div>The present article focuses on probable challenges and ideal roadmaps for standardization and characterization of such herbal as well as metallic-mineral Ayurvedic medicines being used for various simple and complex diseases like cancer and their treatments. It is emphasized that Ayurvedic manufacturing procedures should be followed meticulously and the finished product be characterized thoroughly using advanced pharmaceutical and analytical techniques. It is also accentuated that detailed monographs or dossiers including shelf-life studies need to be officially published for knowledge dissemination and worldwide acceptance. Finally, safety and efficacy studies as per modern pharmacology ought to be conducted in suitable animal models for the judicious use of these medicines. Mainstream or adjuvant treatment of dreadful diseases such as cancer with Ayurvedic medicines will only be fruitful through rational experimentation and ethical reporting.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 100954"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of hemangiomatous ulcer: A case report 阿育吠陀疗法治疗血管瘤性溃疡:病例报告
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.101056
Praveen Kumar Yadav , Laxmikant S.D.
The most frequent infantile tumor is a hemangioma, and its most common complication is ulceration. A quickly progressing ulcer called a hemangioma can also result in secondary infection. The mechanism of ulcer formation is unknown but is thought to develop during the rapid growth phase. Infantile hemangiomas are diagnosed clinically, based on the progression of the lesion's history and a clinical examination. Physical interventions (laser surgery, cryosurgery, excision) and systemic corticosteroids or beta-blockers are the usual course of treatment; all carry the potential for substantial side effects. A two-month young female baby approached us, with a diagnosis of hemangiomatous ulcer. Skin grafting was advised by a plastic surgeon, but the baby's parents approached for Ayurveda treatment. The case was treated with oral medicine bilwadi agada and external treatments vranaprakshalana with triphala kwatha and jatyadi taila local application for 2 months. There was complete healing of the ulcer.
最常见的婴儿肿瘤是血管瘤,其最常见的并发症是溃疡。称为血管瘤的溃疡进展迅速,也可能导致继发感染。溃疡形成的机制尚不清楚,但据认为是在快速生长期形成的。婴儿血管瘤是根据病史和临床检查的进展情况进行临床诊断的。物理干预(激光手术、冷冻手术、切除术)和全身用皮质类固醇激素或β-受体阻滞剂是通常的治疗方法,但所有这些方法都可能产生很大的副作用。我们接诊了一名两个月大的女婴,诊断为血管瘤性溃疡。整形外科医生建议进行植皮手术,但婴儿的父母要求进行阿育吠陀治疗。该病例接受了为期 2 个月的口服药物 bilwadi agada 和外用疗法 vranaprakshalana 以及 triphala kwatha 和 jatyadi taila 局部涂抹。溃疡完全愈合。
{"title":"Ayurvedic management of hemangiomatous ulcer: A case report","authors":"Praveen Kumar Yadav ,&nbsp;Laxmikant S.D.","doi":"10.1016/j.jaim.2024.101056","DOIUrl":"10.1016/j.jaim.2024.101056","url":null,"abstract":"<div><div>The most frequent infantile tumor is a hemangioma, and its most common complication is ulceration. A quickly progressing ulcer called a hemangioma can also result in secondary infection. The mechanism of ulcer formation is unknown but is thought to develop during the rapid growth phase. Infantile hemangiomas are diagnosed clinically, based on the progression of the lesion's history and a clinical examination. Physical interventions (laser surgery, cryosurgery, excision) and systemic corticosteroids or beta-blockers are the usual course of treatment; all carry the potential for substantial side effects. A two-month young female baby approached us, with a diagnosis of hemangiomatous ulcer. Skin grafting was advised by a plastic surgeon, but the baby's parents approached for Ayurveda treatment. The case was treated with oral medicine bilwadi agada and external treatments vranaprakshalana with triphala kwatha and jatyadi taila local application for 2 months. There was complete healing of the ulcer.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 101056"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142437850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibacterial and cytotoxicity properties of a polyherbal mouthwash containing Achyranthes aspera and Trachyspermum ammi against selected periodontal pathogens 含有牛膝和Trachyspermum ammi的多草本漱口水对特定牙周病原体的抗菌和细胞毒性特性。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.101046
Ram Surath Kumar , Anil V. Ankola , Mahantesh B. Nagamoti , Roopali M. Sankeshwari , Kishori P. Sutar , Shushant I. Jigan , Atrey J. Pai Khot

Background

Chlorhexidine (CHX) is considered as a gold standard for its antibacterial efficacy and substantivity in chemical plaque control. However, some adverse effects are associated with its prolonged use. Herbal medicines like Achyranthes aspera and Trachyspermum ammi have been used in many clinical conditions, and they appear to be a valuable substitute next to CHX in the management of periodontal diseases.

Objective

This in vitro study was designed to assess and compare the antibacterial potential and cytotoxic effects of novel polyherbal mouthwash containing A. aspera and T. ammi with 0.2% CHX mouthwash against Porphyromonas gingivalis, Tannerella forsythia, and Aggregatibacter actinomycetemcomitans.

Methods

Ethanolic extracts of A. aspera and T. ammi were prepared by the Soxhlet apparatus method and were subjected to preliminary phytochemical screening. The individual plant extracts and the plant extract mixture (PEM) of A. aspera and T. ammi in the ratio of 1:1, 2:1, 1:2 (w/v) were assessed for minimum inhibitory concentration (resazurin microtitre assay) and minimum bactericidal concentration (spread plating method) against selected periodontal pathogens in comparison to CHX. The polyherbal mouthwash was assessed for zone of inhibition (well diffusion method) and cytotoxicity (MTT assay) on adult human gingival fibroblasts. All the experiments were performed in triplicate.

Results

The antibacterial activity was evident in the PEMs, and polyherbal mouthwash against tested periodontal pathogens and was comparable to CHX. The cytotoxicity assay findings confirmed that polyherbal mouthwash exhibited 82.1% of surviving cells which proved good biocompatibility.

Conclusion

A. aspera and T. ammi based mouthwash possess comparable antibacterial activity against periodontal pathogens when compared to CHX.
背景:洗必泰(CHX)因其抗菌功效和在化学牙菌斑控制方面的有效性而被视为黄金标准。然而,长期使用会产生一些不良反应。Achyranthes aspera 和 Trachyspermum ammi 等草药已在许多临床病例中使用,在牙周疾病的治疗中,它们似乎是 CHX 的重要替代品:本体外研究旨在评估和比较含有香紫苏和安米的新型多草本漱口水与 0.2% CHX 漱口水对牙龈卟啉单胞菌、连翘菌和放线菌的抗菌潜力和细胞毒性作用:用索氏提取器法制备了 A. aspera 和 T. ammi 的乙醇提取物,并对其进行了初步的植物化学筛选。以 1:1、2:1、1:2(w/v)的比例分别评估了天南星和安米的单个植物提取物和植物提取物混合物(PEM)对选定牙周病原体的最小抑菌浓度(雷沙唑啉微滴定法)和最小杀菌浓度(涂布平板法),并与 CHX 进行了比较。评估了多草本漱口水对成人牙龈成纤维细胞的抑制区(井扩散法)和细胞毒性(MTT 法)。所有实验均一式三份:结果:PEMs 和多草本漱口水对测试的牙周病原体具有明显的抗菌活性,与 CHX 不相上下。细胞毒性试验结果表明,多草本漱口水中存活细胞的比例为 82.1%,证明其具有良好的生物相容性:结论:与 CHX 相比,A. aspera 和 T. ammi 漱口水对牙周病原体具有相当的抗菌活性。
{"title":"Antibacterial and cytotoxicity properties of a polyherbal mouthwash containing Achyranthes aspera and Trachyspermum ammi against selected periodontal pathogens","authors":"Ram Surath Kumar ,&nbsp;Anil V. Ankola ,&nbsp;Mahantesh B. Nagamoti ,&nbsp;Roopali M. Sankeshwari ,&nbsp;Kishori P. Sutar ,&nbsp;Shushant I. Jigan ,&nbsp;Atrey J. Pai Khot","doi":"10.1016/j.jaim.2024.101046","DOIUrl":"10.1016/j.jaim.2024.101046","url":null,"abstract":"<div><h3>Background</h3><div>Chlorhexidine (CHX) is considered as a gold standard for its antibacterial efficacy and substantivity in chemical plaque control. However, some adverse effects are associated with its prolonged use. Herbal medicines like <em>Achyranthes aspera</em> and <em>Trachyspermum ammi</em> have been used in many clinical conditions, and they appear to be a valuable substitute next to CHX in the management of periodontal diseases.</div></div><div><h3>Objective</h3><div>This <em>in vitro</em> study was designed to assess and compare the antibacterial potential and cytotoxic effects of novel polyherbal mouthwash containing <em>A. aspera</em> and <em>T. ammi</em> with 0.2% CHX mouthwash against <em>Porphyromonas gingivalis, Tannerella forsythia,</em> and <em>Aggregatibacter actinomycetemcomitans</em>.</div></div><div><h3>Methods</h3><div>Ethanolic extracts of <em>A. aspera</em> and <em>T. ammi</em> were prepared by the Soxhlet apparatus method and were subjected to preliminary phytochemical screening. The individual plant extracts and the plant extract mixture (PEM) of <em>A. aspera</em> and <em>T. ammi</em> in the ratio of 1:1, 2:1, 1:2 (<em>w/v</em>) were assessed for minimum inhibitory concentration (resazurin microtitre assay) and minimum bactericidal concentration (spread plating method) against selected periodontal pathogens in comparison to CHX. The polyherbal mouthwash was assessed for zone of inhibition (well diffusion method) and cytotoxicity (MTT assay) on adult human gingival fibroblasts. All the experiments were performed in triplicate.</div></div><div><h3>Results</h3><div>The antibacterial activity was evident in the PEMs, and polyherbal mouthwash against tested periodontal pathogens and was comparable to CHX. The cytotoxicity assay findings confirmed that polyherbal mouthwash exhibited 82.1% of surviving cells which proved good biocompatibility.</div></div><div><h3>Conclusion</h3><div><em>A. aspera</em> and <em>T. ammi</em> based mouthwash possess comparable antibacterial activity against periodontal pathogens when compared to CHX.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 101046"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies 大叶芝麻富含黄酮类成分的肝保护作用:体内、体外和分子对接研究的结果。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.101036
Anitha Kuttiappan , Santenna Chenchula , Murugesan Vanangamudi , Shvetank Bhatt , Radhika Chikatipalli , P Shaila Bhanu , Nagaraju Bandaru
<div><h3>Background</h3><p>Phytochemicals and their derivatives are promising target drugs for various ailments and have served as therapeutic agents for several decades. Using <em>in vivo</em> and <em>in vitro</em> models and molecular docking, this study investigated the pharmacological potential of a flavonoid-rich fraction of the ethanolic extract of <em>Sesbania grandiflora</em> (SG).</p></div><div><h3>Objectives</h3><p>This research aimed to determine whether flavonoid-rich whole-plant extracts of SGs have any cytoprotective or <em>in vivo</em> hepatoprotective effects. Additionally, the study was intended to elucidate the molecular connections between the discovered flavonoid flavonols and PPARα target proteins linked to liver problems, for which an in silico molecular docking investigation was performed.</p></div><div><h3>Materials and methods</h3><p>To separate the flavonoid components, the entire <em>Sesbania grandiflora</em> plant was first extracted using ethanol as a solvent by soxhlet extraction. The resulting ethanolic extract was then fractionated. The cytoprotective and hepatoprotective properties were evaluated via <em>in vitro</em> and <em>in vivo</em> experiments. SGOT, SGPT, triglyceride, bilirubin, and total protein levels were used to evaluate hepatotoxicity in animal models. <em>In vitro</em> studies on Hepatocellular Carcinoma G2 (HepG2) cell lines have examined their cytotoxic effects and antioxidant activity. The most promising flavonoid-flavanol compounds were identified by conducting molecular docking studies against PPARα target protein (PDB ID: <span><span>3VI8</span><svg><path></path></svg></span>) using MOE software.</p></div><div><h3>Results</h3><p><em>In vivo</em>, the serum levels of SGOT, SGPT, total triglyceride and total bilirubin were measured in experimental animals treated with the flavonoid-rich ethanolic extract of SG. Significant reductions in the levels of these hepatic injury markers were observed, indicating the hepatoprotective potential of the extract. Elevated levels of liver biomarkers in the untreated group indicated liver injury or dysfunction. The treated groups showed significant restoration of these biomarkers, suggesting the hepatoprotective potential of <em>SG</em>. The IC<sub>50</sub> value for the total flavonoid content of SG was 190.28 μg/ml, indicating its safety in inhibiting HepG2 cell growth. Flavonoid treatment decreased cell viability but did not affect antioxidant parameters in hepatocytes. In addition, SG restored the damaged hepatocyte architecture. Molecular docking studies revealed the binding affinities of flavonoids for PPARα. These findings suggest that a promising lead candidate for the development of therapeutic medicines against anti-TB drug-induced hepatotoxicity has been identified.</p></div><div><h3>Conclusion</h3><p>Our findings demonstrate the hepatoprotective potential of the flavonoid-rich fraction of <em>Sesbania grandiflora</em> both <em>in vivo</em> and <em>
背景:几十年来,植物化学物质及其衍生物一直是治疗各种疾病的有前途的靶向药物。本研究利用体内和体外模型以及分子对接,研究了大叶芝麻(SG)乙醇提取物中富含黄酮类成分的药理潜力:本研究旨在确定富含黄酮类化合物的 SG 全植物提取物是否具有细胞保护或体内肝脏保护作用。此外,该研究还旨在阐明已发现的类黄酮黄酮醇与与肝脏问题有关的 PPARα 靶蛋白之间的分子联系,并为此进行了硅学分子对接调查:为了分离黄酮类成分,首先使用乙醇作为溶剂,通过索氏提取法提取整株大叶芝麻。然后对得到的乙醇提取物进行分馏。通过体外和体内实验对其细胞保护和肝脏保护特性进行了评估。采用 SGOT、SGPT、甘油三酯、胆红素和总蛋白水平来评估动物模型的肝毒性。对肝细胞癌 G2(HepG2)细胞系进行的体外研究检验了它们的细胞毒性作用和抗氧化活性。通过使用 MOE 软件对 PPARα 靶蛋白(PDB ID:3VI8)进行分子对接研究,确定了最有前景的黄酮-黄烷醇化合物:用富含黄酮的 SG 乙醇提取物对实验动物进行体内血清 SGOT、SGPT、总甘油三酯和总胆红素水平的测定。结果表明,这些肝损伤标志物的水平明显降低,表明萃取物具有保护肝脏的潜力。未处理组的肝脏生物标志物水平升高表明肝脏损伤或功能障碍。治疗组的这些生物标志物水平明显恢复,表明 SG 具有保护肝脏的潜力。SG 总黄酮含量的 IC50 值为 190.28 μg/ml,表明其在抑制 HepG2 细胞生长方面具有安全性。类黄酮处理可降低细胞活力,但不会影响肝细胞的抗氧化参数。此外,SG 还能恢复受损的肝细胞结构。分子对接研究揭示了类黄酮与 PPARα 的结合亲和力。这些研究结果表明,我们已经找到了一种很有希望的候选药物,可用于开发抗结核药物引起的肝毒性的治疗药物:我们的研究结果表明,富含黄酮类成分的大叶芝麻在体内和体外都具有保肝潜力。这项研究对其作用机制提供了宝贵的见解,突出了其在治疗肝脏疾病方面的应用前景。本研究强调了五加科植物总黄酮富集部分的保肝和细胞保护潜力。
{"title":"Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studies","authors":"Anitha Kuttiappan ,&nbsp;Santenna Chenchula ,&nbsp;Murugesan Vanangamudi ,&nbsp;Shvetank Bhatt ,&nbsp;Radhika Chikatipalli ,&nbsp;P Shaila Bhanu ,&nbsp;Nagaraju Bandaru","doi":"10.1016/j.jaim.2024.101036","DOIUrl":"10.1016/j.jaim.2024.101036","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;p&gt;Phytochemicals and their derivatives are promising target drugs for various ailments and have served as therapeutic agents for several decades. Using &lt;em&gt;in vivo&lt;/em&gt; and &lt;em&gt;in vitro&lt;/em&gt; models and molecular docking, this study investigated the pharmacological potential of a flavonoid-rich fraction of the ethanolic extract of &lt;em&gt;Sesbania grandiflora&lt;/em&gt; (SG).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectives&lt;/h3&gt;&lt;p&gt;This research aimed to determine whether flavonoid-rich whole-plant extracts of SGs have any cytoprotective or &lt;em&gt;in vivo&lt;/em&gt; hepatoprotective effects. Additionally, the study was intended to elucidate the molecular connections between the discovered flavonoid flavonols and PPARα target proteins linked to liver problems, for which an in silico molecular docking investigation was performed.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Materials and methods&lt;/h3&gt;&lt;p&gt;To separate the flavonoid components, the entire &lt;em&gt;Sesbania grandiflora&lt;/em&gt; plant was first extracted using ethanol as a solvent by soxhlet extraction. The resulting ethanolic extract was then fractionated. The cytoprotective and hepatoprotective properties were evaluated via &lt;em&gt;in vitro&lt;/em&gt; and &lt;em&gt;in vivo&lt;/em&gt; experiments. SGOT, SGPT, triglyceride, bilirubin, and total protein levels were used to evaluate hepatotoxicity in animal models. &lt;em&gt;In vitro&lt;/em&gt; studies on Hepatocellular Carcinoma G2 (HepG2) cell lines have examined their cytotoxic effects and antioxidant activity. The most promising flavonoid-flavanol compounds were identified by conducting molecular docking studies against PPARα target protein (PDB ID: &lt;span&gt;&lt;span&gt;3VI8&lt;/span&gt;&lt;svg&gt;&lt;path&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/span&gt;) using MOE software.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;&lt;em&gt;In vivo&lt;/em&gt;, the serum levels of SGOT, SGPT, total triglyceride and total bilirubin were measured in experimental animals treated with the flavonoid-rich ethanolic extract of SG. Significant reductions in the levels of these hepatic injury markers were observed, indicating the hepatoprotective potential of the extract. Elevated levels of liver biomarkers in the untreated group indicated liver injury or dysfunction. The treated groups showed significant restoration of these biomarkers, suggesting the hepatoprotective potential of &lt;em&gt;SG&lt;/em&gt;. The IC&lt;sub&gt;50&lt;/sub&gt; value for the total flavonoid content of SG was 190.28 μg/ml, indicating its safety in inhibiting HepG2 cell growth. Flavonoid treatment decreased cell viability but did not affect antioxidant parameters in hepatocytes. In addition, SG restored the damaged hepatocyte architecture. Molecular docking studies revealed the binding affinities of flavonoids for PPARα. These findings suggest that a promising lead candidate for the development of therapeutic medicines against anti-TB drug-induced hepatotoxicity has been identified.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;Our findings demonstrate the hepatoprotective potential of the flavonoid-rich fraction of &lt;em&gt;Sesbania grandiflora&lt;/em&gt; both &lt;em&gt;in vivo&lt;/em&gt; and &lt;em&gt;","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 101036"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001517/pdfft?md5=0f7fc8a45bc8f15450e3737f599c90e3&pid=1-s2.0-S0975947624001517-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-cultural study on the uses of traditional herbal medicine to treat various women's health issues in Northeast India 关于印度东北部地区使用传统草药治疗各种妇女健康问题的跨文化研究。
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.101024
Klaret Kropi, K.P. Jastone, Sweety Angelirie Kharumnuid, Hemanta Kumar Das, Moses M. Naga
<div><h3>Background</h3><div>This cross-cultural study conducted in the diverse regions of Assam, Meghalaya, and Manipur sheds light on the common utilization of five specific medicinal plants among indigenous communities residing in these areas.</div></div><div><h3>Objectives</h3><div>The main focus of this study is to document and compare the traditional medicinal plant used and the knowledge and practices related to women's health issues in different cultures; to identify commonalities and differences in the use of medicinal plants across cultures and various medicinal plants used traditionally by the indigenous communities to treat women's health problems according to their indigenous name, scientific name.</div></div><div><h3>Materials and methods</h3><div>The study used a survey method and a pre-structured interview schedule through one-on-one interactive communication and field observation. The authors collected data from three different states, i.e., Assam (Karbi Anglong district & Udalguri district), Meghalaya (East Khasi Hills district), and Manipur (Senapati district) by personally meeting and interacting with traditional herbal medicinal practitioners. For this study, 10 practitioners from each area of study were interviewed. During the data collection process, the vernacular name of the medicinal plant, methods of preparation, mode of application, and probable dosage were compiled and documented involving practitioners belonging to four different communities, i.e, Bodo, Karbi, Khasi, and Poumai Naga of the selected states.</div></div><div><h3>Results</h3><div>A total of 39 plant species were meticulously collected and documented across the Karbi Anglong district and Udalguri district in Assam, East Khasi Hills district in Meghalaya, and Senapati district in Manipur. Turmeric (<em>Curcuma longa</em>), ginger (<em>Zingiber officinale</em>), gooseberry (<em>Emblica officinalis</em>), papaya (<em>Carica papaya</em>), and passion fruit (<em>Passiflora edulis)</em> have emerged as common medicinal resources within these communities. Poaceae, represented by 5 species, emerged as the dominant family among the collected plants, highlighting the diversity and significance of these botanical remedies. <em>Zingiber officinale</em> Roscoe " has the highest usage report of 18 with an RFC (Relative frequency citation) of 0.45.</div></div><div><h3>Conclusion</h3><div>The study's findings reveal a rich repository of traditional herbal knowledge in the northeast regions of India. Notably, the indigenous communities of these regions use plant resources to cure a wide range of ailments. This study emphasizes the necessity of documenting, preserving, and transmitting traditional herbal medicinal knowledge for both cultural and practical reasons. It also provides vital insights into the importance of cross-cultural study in promoting different cultures, the richness of traditional medicinal knowledge by engaging with diverse cultures and demonstrates
背景:这项在阿萨姆邦、梅加拉亚邦和曼尼普尔邦不同地区进行的跨文化研究揭示了居住在这些地区的土著社区对五种特定药用植物的共同利用:这项在阿萨姆邦、梅加拉亚邦和曼尼普尔邦不同地区进行的跨文化研究揭示了居住在这些地区的土著社区对五种特定药用植物的共同利用:本研究的主要重点是记录和比较不同文化中使用的传统药用植物以及与妇女健康问题相关的知识和做法;确定不同文化中使用药用植物的共性和差异,以及土著社区根据其土著名称和学名传统上用于治疗妇女健康问题的各种药用植物:本研究采用了调查法和预设的访谈表,通过一对一的互动交流和实地观察进行。作者在三个不同的邦,即阿萨姆邦(卡比昂隆县和乌达尔古里县)、梅加拉亚邦(东卡西山县)和曼尼普尔邦(塞纳帕蒂县),通过与传统草药从业者的亲自会面和交流收集数据。在这项研究中,每个研究地区都采访了 10 名从业人员。在数据收集过程中,对药用植物的方言名称、制备方法、应用方式和可能的用量进行了汇编和记录,参与人员来自四个不同的社区,即所选邦的博多、卡比、卡西和普迈那加:在阿萨姆邦的卡比安格隆地区和乌达尔古里地区、梅加拉亚邦的东卡西山地区以及曼尼普尔邦的塞纳帕蒂地区,共精心收集并记录了 39 种植物。姜黄(Curcuma longa)、生姜(Zingiber officinale)、鹅掌楸(Emblica officinalis)、木瓜(Carica papaya)和西番莲(Passiflora edulis)已成为这些社区的常见药用资源。在采集的植物中,以 5 个物种为代表的草本植物科(Poaceae)是最主要的科,这突出了这些植物疗法的多样性和重要性。Zingiber officinale Roscoe "的使用率最高,有 18 种,RFC(相对频率引用)为 0.45:研究结果揭示了印度东北部地区丰富的传统草药知识宝库。值得注意的是,这些地区的原住民社区利用植物资源治疗各种疾病。这项研究强调,出于文化和实用的原因,有必要记录、保存和传播传统草药知识。它还就跨文化研究在促进不同文化方面的重要性、通过与不同文化接触而获得的丰富传统医药知识提供了重要见解,并展示了将传统医药纳入现代医疗保健系统的可能性,特别是在治疗这些文化多元地区妇女的健康问题方面。
{"title":"Cross-cultural study on the uses of traditional herbal medicine to treat various women's health issues in Northeast India","authors":"Klaret Kropi,&nbsp;K.P. Jastone,&nbsp;Sweety Angelirie Kharumnuid,&nbsp;Hemanta Kumar Das,&nbsp;Moses M. Naga","doi":"10.1016/j.jaim.2024.101024","DOIUrl":"10.1016/j.jaim.2024.101024","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;This cross-cultural study conducted in the diverse regions of Assam, Meghalaya, and Manipur sheds light on the common utilization of five specific medicinal plants among indigenous communities residing in these areas.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectives&lt;/h3&gt;&lt;div&gt;The main focus of this study is to document and compare the traditional medicinal plant used and the knowledge and practices related to women's health issues in different cultures; to identify commonalities and differences in the use of medicinal plants across cultures and various medicinal plants used traditionally by the indigenous communities to treat women's health problems according to their indigenous name, scientific name.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Materials and methods&lt;/h3&gt;&lt;div&gt;The study used a survey method and a pre-structured interview schedule through one-on-one interactive communication and field observation. The authors collected data from three different states, i.e., Assam (Karbi Anglong district &amp; Udalguri district), Meghalaya (East Khasi Hills district), and Manipur (Senapati district) by personally meeting and interacting with traditional herbal medicinal practitioners. For this study, 10 practitioners from each area of study were interviewed. During the data collection process, the vernacular name of the medicinal plant, methods of preparation, mode of application, and probable dosage were compiled and documented involving practitioners belonging to four different communities, i.e, Bodo, Karbi, Khasi, and Poumai Naga of the selected states.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 39 plant species were meticulously collected and documented across the Karbi Anglong district and Udalguri district in Assam, East Khasi Hills district in Meghalaya, and Senapati district in Manipur. Turmeric (&lt;em&gt;Curcuma longa&lt;/em&gt;), ginger (&lt;em&gt;Zingiber officinale&lt;/em&gt;), gooseberry (&lt;em&gt;Emblica officinalis&lt;/em&gt;), papaya (&lt;em&gt;Carica papaya&lt;/em&gt;), and passion fruit (&lt;em&gt;Passiflora edulis)&lt;/em&gt; have emerged as common medicinal resources within these communities. Poaceae, represented by 5 species, emerged as the dominant family among the collected plants, highlighting the diversity and significance of these botanical remedies. &lt;em&gt;Zingiber officinale&lt;/em&gt; Roscoe \" has the highest usage report of 18 with an RFC (Relative frequency citation) of 0.45.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;The study's findings reveal a rich repository of traditional herbal knowledge in the northeast regions of India. Notably, the indigenous communities of these regions use plant resources to cure a wide range of ailments. This study emphasizes the necessity of documenting, preserving, and transmitting traditional herbal medicinal knowledge for both cultural and practical reasons. It also provides vital insights into the importance of cross-cultural study in promoting different cultures, the richness of traditional medicinal knowledge by engaging with diverse cultures and demonstrates ","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 101024"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624001396/pdfft?md5=0d1e78e724747eaf81fd946f8f26c940&pid=1-s2.0-S0975947624001396-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of post-hysterectomy urinary incontinence with composite Ayurveda treatment – A case report 用阿育吠陀复合疗法治疗子宫切除术后尿失禁--病例报告
IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2024-09-01 DOI: 10.1016/j.jaim.2024.100961
Ranjani Karthik Pandit
This is a case report of a patient who developed urinary incontinence after undergoing abdominal hysterectomy. This was successfully treated with Ayurvedic treatment procedures. A 63-year-old lady was suffering from urinary incontinence, which developed after hysterectomy. It did not subside even after undergoing trans vaginal taping. She was treated with Ayurvedic procedures and medicines for a period of 2 and a half months from 4th of March 2016 to 26th of May 2016. Matrabasti (medicated enema) and Madhutailika basti (enema treatment with honey and oil), along with other palliative medicines – Sukumara ghrita, Chandraprabha vati, Shilajatu, Mahakalyanaka kashaya, Mamsapachaka ghana vati and Mahatiktaka ghrita were given to the patient. Urinary incontinence reduced to dribbling of urine after Matra basti and after the second course of Basti (medicated enema), that is after one and half months, patient stopped using diapers and was relieved from incontinence. This case report summarises the effective management of urinary incontinence by adopting basti (enema) treatment along with other palliative ayurvedic medicine.
本病例报告了一名患者在接受腹部子宫切除术后出现尿失禁的情况。采用阿育吠陀治疗程序成功治疗了该病。一位 63 岁的女士在子宫切除术后出现尿失禁。即使接受了经阴道粘贴术,尿失禁症状仍未缓解。从 2016 年 3 月 4 日至 2016 年 5 月 26 日,她接受了为期两个半月的阿育吠陀疗法和药物治疗。患者接受了 Matrabasti(药物灌肠)和 Madhutailika basti(用蜂蜜和油进行灌肠治疗)以及其他缓和药物 - Sukumara ghrita、Chandraprabha vati、Shilajatu、Mahakalyanaka kashaya、Mamsapachaka ghana vati 和 Mahatiktaka ghrita。在 Matra basti 之后,尿失禁症状减轻为滴尿,在第二个 Basti 疗程(药物灌肠)之后,即一个半月之后,患者停止使用尿布,尿失禁症状得到缓解。本病例报告总结了通过采用巴斯提(灌肠)疗法和其他缓解性阿育吠陀疗法有效治疗尿失禁的情况。
{"title":"Management of post-hysterectomy urinary incontinence with composite Ayurveda treatment – A case report","authors":"Ranjani Karthik Pandit","doi":"10.1016/j.jaim.2024.100961","DOIUrl":"10.1016/j.jaim.2024.100961","url":null,"abstract":"<div><div>This is a case report of a patient who developed urinary incontinence after undergoing abdominal hysterectomy. This was successfully treated with Ayurvedic treatment procedures. A 63-year-old lady was suffering from urinary incontinence, which developed after hysterectomy. It did not subside even after undergoing trans vaginal taping. She was treated with Ayurvedic procedures and medicines for a period of 2 and a half months from 4<sup>th</sup> of March 2016 to 26<sup>th</sup> of May 2016. <em>Matrabasti</em> (medicated enema) and <em>Madhutailika</em> <em>basti</em> (enema treatment with honey and oil), along with other palliative medicines – <em>S</em><em>ukumara ghrita, Chandraprabha vati,</em> <em>S</em><em>hilajatu,</em> <em>M</em><em>ahakalyanaka kashaya,</em> <em>M</em><em>amsapachaka ghana vati and Mahatiktaka ghrita</em> were given to the patient. Urinary incontinence reduced to dribbling of urine after Matra basti and after the second course of <em>B</em><em>asti</em> (medicated enema), that is after one and half months, patient stopped using diapers and was relieved from incontinence. This case report summarises the effective management of urinary incontinence by adopting basti (enema) treatment along with other palliative ayurvedic medicine.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 5","pages":"Article 100961"},"PeriodicalIF":1.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142323999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1